AB Science S.A.
EPA:AB.PA
Overview | Financials
Company Name | AB Science S.A. |
Symbol | AB.PA |
Currency | EUR |
Price | 1.032 |
Market Cap | 54,051,000 |
Dividend Yield | 0% |
52-week-range | 0.88 - 4.465 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Alain Moussy MBA |
Website | https://www.ab-science.com |
An error occurred while fetching data.
About AB Science S.A.
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD